2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
---|---|---|---|---|---|
营业收入(元) | |||||
抗肿瘤类(元) | 334,222,414.39 | 616,952,451.86 | 310,799,102.35 | 651,411,889.35 | 332,388,603.53 |
消化类(元) | 145,636,980.99 | 299,012,277.35 | 172,976,228.09 | 856,005,513.78 | 502,663,567.64 |
抗感染类(元) | 259,078,119.47 | 282,340,046.29 | - | - | - |
慢性病类(元) | 155,369,553.15 | 205,136,693.90 | - | - | - |
其他(元) | 15,311,428.00 | 26,247,398.89 | 222,668,690.77 | 351,546,539.49 | 168,720,758.63 |
营业成本(元) | |||||
抗肿瘤类(元) | 26,457,343.29 | 57,462,290.63 | 30,672,086.65 | 49,892,754.54 | 24,628,322.78 |
消化类(元) | 40,669,403.79 | 81,344,572.97 | 54,416,139.75 | 98,226,915.21 | 41,929,155.07 |
抗感染类(元) | 47,509,385.29 | 57,380,617.58 | - | - | - |
慢性病类(元) | 40,448,186.74 | 62,978,716.92 | - | - | - |
其他(元) | 5,919,394.73 | 10,128,796.06 | 52,147,556.71 | 95,012,595.99 | 41,786,707.93 |
毛利(元) | |||||
抗肿瘤类(元) | 307,765,071.10 | 559,490,161.23 | 280,127,015.70 | 601,519,134.81 | 307,760,280.75 |
消化类(元) | 104,967,577.20 | 217,667,704.38 | 118,560,088.34 | 757,778,598.57 | 460,734,412.57 |
抗感染类(元) | 211,568,734.18 | 224,959,428.71 | - | - | - |
慢性病类(元) | 114,921,366.41 | 142,157,976.98 | - | - | - |
其他(元) | 9,392,033.27 | 16,118,602.83 | 170,521,134.06 | 256,533,943.50 | 126,934,050.70 |
毛利率(%) | |||||
抗肿瘤类(%) | 92.08 | 90.69 | 90.13 | 92.34 | 92.59 |
消化类(%) | 72.07 | 72.80 | 68.54 | 88.52 | 91.66 |
抗感染类(%) | 81.66 | 79.68 | - | - | - |
慢性病类(%) | 73.97 | 69.30 | - | - | - |
其他(%) | 61.34 | 61.41 | 76.58 | 72.97 | 75.23 |
收入构成(%) | |||||
抗肿瘤类(%) | 36.74 | 43.15 | 43.99 | 35.04 | 33.11 |
消化类(%) | 16.01 | 20.91 | 24.49 | 46.05 | 50.08 |
抗感染类(%) | 28.48 | 19.75 | - | - | - |
慢性病类(%) | 17.08 | 14.35 | - | - | - |
其他(%) | 1.68 | 1.84 | 31.52 | 18.91 | 16.81 |
毛利构成(%) | |||||
抗肿瘤类(%) | 41.11 | 48.22 | 49.21 | 37.23 | 34.37 |
消化类(%) | 14.02 | 18.76 | 20.83 | 46.90 | 51.45 |
抗感染类(%) | 28.26 | 19.39 | - | - | - |
慢性病类(%) | 15.35 | 12.25 | - | - | - |
其他(%) | 1.25 | 1.39 | 29.96 | 15.88 | 14.18 |